1,026
Views
39
CrossRef citations to date
0
Altmetric
Author's View

Macrophages increase the resistance of pancreatic adenocarcinoma cells to gemcitabine by upregulating cytidine deaminase

&
Article: e27231 | Received 13 Nov 2013, Accepted 16 Nov 2013, Published online: 10 Dec 2013

References

  • Andre F, Berrada N, Desmedt C. Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients. Curr Opin Oncol 2010; 22:547 - 51; http://dx.doi.org/10.1097/CCO.0b013e32833fb384; PMID: 20842030
  • Zheng Y, Cai Z, Wang S, Zhang X, Qian J, Hong S, Li H, Wang M, Yang J, Yi Q. Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis. Blood 2009; 114:3625 - 8; http://dx.doi.org/10.1182/blood-2009-05-220285; PMID: 19710503
  • De Palma M, Lewis CE. Cancer: Macrophages limit chemotherapy. Nature 2011; 472:303 - 4; http://dx.doi.org/10.1038/472303a; PMID: 21512566
  • Mitchem JB, Brennan DJ, Knolhoff BL, Belt BA, Zhu Y, Sanford DE, Belaygorod L, Carpenter D, Collins L, Piwnica-Worms D, et al. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Cancer Res 2013; 73:1128 - 41; http://dx.doi.org/10.1158/0008-5472.CAN-12-2731; PMID: 23221383
  • Morgan MA, Parsels LA, Parsels JD, Mesiwala AK, Maybaum J, Lawrence TS. Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine. Cancer Res 2005; 65:6835 - 42; http://dx.doi.org/10.1158/0008-5472.CAN-04-2246; PMID: 16061666
  • Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J, Davis A, Mongare MM, Gould J, Frederick DT, et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 2012; 487:500 - 4; http://dx.doi.org/10.1038/nature11183; PMID: 22763439
  • Gil Z, Cavel O, Kelly K, Brader P, Rein A, Gao SP, Carlson DL, Shah JP, Fong Y, Wong RJ. Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves. J Natl Cancer Inst 2010; 102:107 - 18; http://dx.doi.org/10.1093/jnci/djp456; PMID: 20068194
  • Yamashina K, Miller BE, Heppner GH. Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line. Cancer Res 1986; 46:2396 - 401; PMID: 3084067
  • Shree T, Olson OC, Elie BT, Kester JC, Garfall AL, Simpson K, Bell-McGuinn KM, Zabor EC, Brogi E, Joyce JA. Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. Genes Dev 2011; 25:2465 - 79; http://dx.doi.org/10.1101/gad.180331.111; PMID: 22156207
  • Dijkgraaf EM, Heusinkveld M, Tummers B, Vogelpoel LT, Goedemans R, Jha V, Nortier JW, Welters MJ, Kroep JR, van der Burg SH. Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment. Cancer Res 2013; 73:2480 - 92; http://dx.doi.org/10.1158/0008-5472.CAN-12-3542; PMID: 23436796